Results 101 to 110 of about 2,746,860 (292)

Occupational airborne contact dermatitis caused by trifluoroacetic acid in an organic chemistry laboratory

open access: yes, 2019
airborne; allergic contact dermatitis; laboratory workers; occupational; organic chemistry; trifluoroacetic ...
최유원, 최혜영, 변지연
core   +1 more source

Annexin 1 Reduces Dermatitis-Induced Itch and Cholestatic Itch through Inhibiting Neuroinflammation and Iron Overload in the Spinal Dorsal Horn of Mice

open access: yesBrain Sciences
The unclear pathogenesis of chronic itch originating from several systemic disorders poses challenges to clinical intervention. Recent studies recapitulate the spinal neurocircuits associated with neuroinflammation and synaptic plasticity responsible for
Tang Li   +8 more
doaj   +1 more source

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases

open access: yesPhytotherapy Research, EarlyView.
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin   +7 more
wiley   +1 more source

Allergic and irritant contact dermatitis to calcipotriol.

open access: yes, 1999
Calcipotriol (Daivonex R; Leo Pharmaceuticals, Zurich, Switzerland) may cause irritation of the skin, whereas allergic reactions are less common. In the present study we describe two patients with different types of reaction patterns, one presenting as ...
Elsner, P., Krayenbühl, B.H.
core  

Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC) [PDF]

open access: yes
Current relevance of positive patch-test reactions guides management in allergic contact dermatitis (ACD), yet its clinical predictors and the use of predictive models in clinical practice remain underused.REDAC4.6 Q1 JCR 20240.981 Q1 SJR 2024No data IDR
Miquel Miquel, Javier   +40 more
core   +1 more source

Photoacoustic Imaging in Immune-Mediated Inflammatory Skin Diseases: Diagnostic and Therapeutic Applications

open access: yesDiagnostics
Background/Objectives: Immune-mediated inflammatory skin diseases (IMSDs), including psoriasis, atopic dermatitis, and systemic sclerosis, are chronic relapsing disorders that impose substantial physical, psychological, and economic burdens.
Nafeixia Maimaitiyili   +5 more
doaj   +1 more source

Epiphora: A Structured Diagnostic Approach for the Otolaryngologist

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Introduction Epiphora, or excessive tearing, has historically been predominantly managed by ophthalmologists. However, as there is substantial overlap between ophthalmic and otolaryngologic anatomy and pathology that may contribute to epiphora, patients with this symptom often present to otolaryngologists as well.
Luke M. O'Neil   +7 more
wiley   +1 more source

Quaternary Ammonium Compounds and Contact Dermatitis: A Review and Considerations During the COVID-19 Pandemic

open access: yesClinical, Cosmetic and Investigational Dermatology, 2023
Chidubem AV Okeke,1 Ramona Khanna,2 Alison Ehrlich3 1Department of Dermatology, Howard University College of Medicine, Washington, DC, USA; 2Georgetown University School of Medicine, Washington, DC, USA; 3Foxhall Dermatology, Washington, DC ...
Okeke CAV, Khanna R, Ehrlich A
doaj  

Large‐Scale Applications of Plasma Technologies: Progresses and Challenges

open access: yesHigh Voltage, EarlyView.
ABSTRACT Plasma technologies convert electrical power into energetic electrons, ions, reactive species, radiation and heat, thereby breaking through the bottleneck of purely thermal or chemical routes and bringing impressive changes to our world. This roadmap reviews the progress and challenges of plasma technologies from a large‐scale and application ...
Pankaj Attri   +51 more
wiley   +1 more source

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy